MAPT and Alzheimer disease: In AD we analyzed the stage-dependent changes in T cell co-stimulatory molecules in peripheral blood with disorder-specific modifications of p-tau, Amyloid-β 1–40, Amyloid-β 1–42 concentrations and the Amyloid-β ratio in CSF.